Management of primitive gastric cancer at university hospitals in LOME. Retrospective stydy of 63 cases;Prise en charge du cancer primitif de l'estomac aux chu de LOME. A propos de 63 cas

Tunisie Medicale

Volumn 82, Issue 8, 2004, Pages 747-752

  Ayite, Ayikoé Etienne ^a   Adodo, Koamivi ^a   Dosseh, Ekué ^a   Abita, Thiare ^a   Ocloo, Atsu ^a  

^a UNIVERSITÉ DE LOMÉ   (Togo)

Author keywords

Cancer; Diagnostic; Stomach; Togo; Treatment

Indexed keywords

CA 72-4 ANTIGEN;

ABDOMINAL PAIN; ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; GASTRECTOMY; GASTROJEJUNOSTOMY; HISTOPATHOLOGY; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RACE; RETROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; SEX RATIO; STOMACH CANCER; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TOGO; UNIVERSITY HOSPITAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TOGO;

EID: 5444272774     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Audigier JC, Lambert R. Epidémiologie des adénocarcinomes gastriques. Rev. Prat. 1978, 28 3409-3417.
2. Barbier J-Ph, Cellier C, Landi B. Tumeurs malignes de l'estomac, 118-128; In: Maladies de l'appareil digestif; Massen 1997, 410, Paris.
3. Rohr S, Meyer C. Impact Internat N° 6, Hépato-gastro- entérologie Cancer de l'estomac: Diagnostic, Evolution, traitement. 1996, 272, 185-191, Paris.
4. Parkin DM. Le cancer dans les pays tropicaux. Carcinologie pratique en Afrique 2000; 3: 24-31
5. Ayité AE, Dosseh E, Sena K, Etey K, Napo-Koura, James K Epidémiologie descriptive des cancers digestifs au Togo J. Afr. Chir. Digest., 2001, 1, 10-16.
6. Trabelsi O, Kalsi K, Haauet K, Kacem C, Kammoun A, El Hachaichi A, et Al. Apprache de l'épidémiologie descriptive des cancers digestifs à travers l'activité d'un service de chirurgie générale. Tunisie médicale N° 6-7, Vol.76, 1998, PP195-199.
7. Glehen O, Traverse-Glehen A, Peyrat P, Français Y, Gérard JP, Vignal J, et Al. Stomach adenocarcinama: Evolution of surgical treatment in a series af 350 cases. Ann. Chir. 2000 Oct; 125 (8): 744-51.
8. Hamdi-Chérif M, Sekfali N, Benlatreche K, Laauamri S, Mahnane A, Guerra D, et Al. Dannées sur l'incidence et la survie du cancer de sétif. Carcinolagie pratique en Afrique, 2000; 3: 16-21.
9. Dieumegard B. Epidemiologie des cancers de l'estomac. La semaine des hôpitaux de Paris 1999, Vol.75, 489-492.
10. Perrat L, Champault G, Quoi de neuf dans le cancer de l'estomoc? Mise au paint: Photographie de la littérature d'une année. J. Chir. 1998, 135, 149, 148-161.
11. Chan Aa, Wang BC, Lam SK. Gastric cancer: Past, present and future. Can. J Gastraenterol. 2001, 15:469-74.
12. Faivre J, Milan M.C, Milan C, Aube H, Banerland P, Les cancers du tube digestif. Concours Méd., 1983, 105, 394-400.
13. Segol Ph, Verwaerde J.C, Foumier J.L, Couque M, Marchand P, Arsene D, et Al. Cancer de l'estomac: Notions fondamentales et diagnostic - Traitement EMC: Estomac-Intestin, Paris 60-9027 A10-A20; 1987; 9.
14. Napo-Koura G. Chomé J. Cancers superficiels de l'estomac à propos de 40 cas. Arch. Anat. Cytol. Path. Versailles, 1988, 36; n° 1-2; 16-22
15. Wang CS, Hsueh S, Chao TC et Al. Prognostic study of gastric cancer without serosal invasion: Reevaluation of the definition of early gastric cancer. J Am Coll. Surg. 1997; 185: 476-480.
16. Wanebo. Epidémiologie et traitement du cancer de l'estomac: Nouveautés en 1992. In Rivoire M, Pathol. Biol. Paris 1992, Vol.40. No 9bis; 4: 939-942.
17. Bernades P, Momberrt J, Potet F, Violette J., Cancer de l'estomac. EMC 1975, 9027 A10.
18. Latif A, Gastric cancer. Update an diagnosis, staging and therapy. Postgrad Med. 1997; 4: 231-237.
19. Asencio F, Aguilo J, Salvador JL. Et Al. Video-laporascopic staging of gastric cancer. A prospective multicenter comparison withnan invasive techniques. Surg. Endosc. 1997; 11: 1153-1158.
20. Pectasides D, Mylonakis A, Kostapaulau M, Papadapaulau M, Triantafilllis D, Varthalitis D. CEA, CA 19-9 and CA-50 in monitoring gastric carcinoma. Am J Clin. Oncol 1997; 20: 348-353.
21. Allgayer H, Heiss MM, Schildberg FW. Review of prognostic factors in gastric. Br J Surg. 1997; 84: 1651-1664.
22. Cushieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Jaypaul V, et Al. Postoperative Morbidity and mortality after D1 and D2 resections for gastric cancer. Preliminary results of the MRC randomised controlled surgical trial. Lancet 1996; 347: 995-999.
23. Sasako M. Risk factor for surgical treatment in Dutch gastric cancer trial. Br J Surg. 1997; 84: 1567-1571.
24. Bonenkamp JJ, Songun I, Hermans J et Al. Randomised comparison of morbidity after D1 and D2 Dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345: 745-748.
25. Seulin P, Carrere N, Bloom E, Pradere B, Tap G, Gouzi JL. Stomach cancer: Have changes in surgical strategy nfluenced the results? Year retrospective study. Ann Chir. 2000; 125: 131-6.